Thus, neuroblastoma cells provide a convenient model system to test whether the potentially conflicting functions of ASCL1 in proliferation and differentiation could be explained by differential activities of this transcription factor at different phases of the cell cycle. This evidence concerns the gene ASCL1 and neuroblastoma.